Dr. Bond is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
460 W 10th Ave
Fl 5
Columbus, OH 43210Phone+1 614-293-3989Fax+1 614-293-4812
Education & Training
- Ohio State University HospitalFellowship, Hematology and Medical Oncology, 2016 - 2019
- Ohio State University HospitalResidency, Internal Medicine, 2012 - 2015
- Indiana University School of MedicineClass of 2012
Certifications & Licensure
- OH State Medical License 2012 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- High-grade B-cell lymphoma, not otherwise specified: CNS involvement and outcomes in a multi-institutional series.Narendranath Epperla, Adam S Zayac, Daniel J Landsburg, Allison M Bock, Grzegorz S Nowakowski
Blood Advances. 2024-10-22 - Brentuximab Vedotin Plus Ibrutinib in Relapsed and Refractory Hodgkin Lymphoma.Matthew Mei, Ni-Chun Tsai, Joycelynne Palmer, Saro Armenian, Robert Chen
Clinical Lymphoma, Myeloma & Leukemia. 2024-08-01 - 1 citationsPostinfusion PD-1+ CD8+ CAR T cells identify patients responsive to CD19 CAR T-cell therapy in non-Hodgkin lymphoma.Nathan Denlinger, No-Joon Song, Xiaoli Zhang, Hyeongseon Jeon, Chelsea Peterson
Blood Advances. 2024-06-25
Abstracts/Posters
- Outcome of Autologous Stem Cell Transplantation Following PD-(L)1 Based Salvage Therapy for Multiply Relapsed Patients with Classic Hodgkin LymphomaDavid A. Bond, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- North American Practice Patterns for PET-2 Positive Hodgkin LymphomaDavid A. Bond, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Outcomes of Patients with Newly-Diagnosed Burkitt Lymphoma (BL) and Central Nervous System (CNS) Involvement Treated in the Modern Era: A Multi-Institutional Real-Worl...David A. Bond, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Join now to see all
Press Mentions
- Mosunetuzumab in Follicular Lymphoma: Durable Responses and Manageable SafetyDecember 19th, 2024
- Surviving CLL: Higher Risk of Other Cancer DXsFebruary 17th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: